Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Ligament or tendon
Reexamination Certificate
2005-11-15
2005-11-15
Pellegrino, Brian E. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Ligament or tendon
C623S014120, C623S917000
Reexamination Certificate
active
06964685
ABSTRACT:
The invention provides compositions and methods for repairing intra-articular and extra-articular tissue including ligament, meniscus, cartilage, tendon, and bone. The method includes contacting the ends of an injured tissue from a patient with a composition. The repair composition includes soluble type 1 collagen, a platelet, and at least one of an extracellular protein and a neutralizing agent.
REFERENCES:
patent: 4458678 (1984-07-01), Yannas et al.
patent: 4578067 (1986-03-01), Cruz
patent: 4808570 (1989-02-01), Michaeli
patent: 4846835 (1989-07-01), Grande
patent: 4955893 (1990-09-01), Yannas et al.
patent: 5171273 (1992-12-01), Silver et al.
patent: 5206023 (1993-04-01), Hunziker
patent: 5655546 (1997-08-01), Halpern
patent: 5713374 (1998-02-01), Pachence et al.
patent: 5749895 (1998-05-01), Sawyer et al.
patent: 5902741 (1999-05-01), Purchio et al.
patent: 6087113 (2000-07-01), Caplan et al.
patent: 6096309 (2000-08-01), Prior et al.
patent: 6117425 (2000-09-01), MacPhee et al.
patent: 6129757 (2000-10-01), Weadock
patent: 6153292 (2000-11-01), Bell et al.
patent: 6171610 (2001-01-01), Vacanti et al.
patent: 0295721 (1988-12-01), None
patent: WO 8500511 (1985-02-01), None
patent: WO 9213565 (1992-08-01), None
patent: WO 9321857 (1993-11-01), None
patent: WO 9525550 (1995-09-01), None
Gerich et al., “Gene transfer to the patellar tendon,”Knee Surg, Sports Traumatol, Arthroscopy(1997) 5:118-123.
Nakamura et al., “A comparison of in vivo gene delivery methods for antisense therapy in ligament healing,”Gene Therapy(1998) 5: 1455-1461.
Nakamura et al., “Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament,”Gene Therapy(1998) 5: 1165-1170.
International Search Report from International Application No. PCT/US02/23885, filed Jul. 29, 2002.
Buck, “Regeneration of Tendon,” 66(1)J. Pathol. Bacteriol.1-18 (1953).
Marshall et al., “The Anterior Cruciate Ligament: A Technique of Repair and Reconstruction,” 143Clin. Orthop.97-106 (Sep. 1979).
Frank et al., “Natural History of Healing in the Repaired Medical Collateral Ligament,” 1(2)J. Orthop. Res.179-188 (1983).
Yannas, et al., “Polymeric template facilitates regeneration of sciatic nerve across 15-millimeter gap,” 8Trans. Soc. Biomater.146 (1985).
Yannans, Collagen vol. 3,Biotechnology,Nimni Ed., p. 87-115 (CRC Press, Boca Raton, Florida, 1989).
Yannas et al., “Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin,”86 Proc. Natl. Acad. Sci USA933-937 (Feb., 1989).
Kato et al., “Formation of continuous collagen fibres: evaluation of biocompatibility and mechanical properties,” 11Biomaterials169-175 (Apr., 1990).
Noyes et al., 72A(8)J. Bone Joint Surg.1125-1136 (Sep. 1990).
Stone et al., “Future Directions: Collagen-Based Prostheses for Meniscal Regeneration,” 252Clinical Orthopaedics and Related Research129-135 (Mar., 1990).
Hefti et al., “Healing of the Transected Anterior Cruciate Ligament in the Rabbit,” 73A (3)J. Bone Joint Surg.373-383 (Mar., 1991).
Geiger et al., “An in vitro assay of anterior cruciate ligament (ACL) and medial collateral ligament (MCL) cell migration,” 30(3)Connect Tissue Res.215-224 (1994).
Louie, L. K., et al., “Development of a collagen-GAG copolymer implant for the study of tendon regeneration,” M331Mat. Res. Soc. Symp. Proc.19-24 (1994).
Spindler et al., “Comparison of collagen synthesis in the peripheral and central region of the canine meniscus,” 303Clinical Orthopaedics256-263 (Jun., 1994).
Troxel, “Delay of skin wound contraction by porous collagen-GAG matrices,” (Ph. D. Thesis, Massachusetts Institute of Technology, 1994) (on file with the MIT Library).
Arendt and Dick, “Knee injury patterns among men and women in collegiate basketball and soccer,” 23(6)Am. J. Sports Med.694-701 (1995).
Deie et al., “High intrinsic healing potential of human anterior cruciate ligament,” 66(1)Acta. Orthop. Scand.28-32 (1995).
Ford et al., “Autologous Collagen Vocal Fold Injection: A Preliminary Clinical Study,” 105Laryngoscope944-948 (Sep., 1995).
Schmidt et al., “Effect of growth factors on the proliferation of fibroblasts from the medial collateral and anterior cruciate ligaments,” 13(2)J. Orthop. Res.184-190 (1995).
Spindler et al., “Regional mitogenic response of the meniscus to platelet-derived growth factor (PDGF-AB),” 13(2)J. Orthop. Res.201-207 (1995).
Weadock et al., “Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment,” 29J. Biomed. Mater. Res.1373-1379 (1995).
Desrosiers et al., “Proliferative and matrix synthesis response of canine anterior cruciate ligament fibroblasts submitted to combined growth factors,” 14(2)J. Orthop. Res.200-208 (1996).
Dye, “The Future Of Anterior Cruciate Ligament Restoration,” 325CLIN. Orthop.130-139 (1996).
Faryniarz, et al., “Myofibroblasts in the healing lapine medial collateral ligament: possible mechanisms of contraction,” 14(2)J. Orthop. Res.228-237 (1996).
Guidance document for testing biodegradable polymer implant devices, Division of General and Restorative Devices, Center for Devices and Radiological Health, U.S. Food and Drug Administration (Apr. 20, 1996).
Jackson et al., “Biologic remodeling after anterior cruciate ligament reconstruction using a collagen matrix derived from demineralized bone: an experimental study in the goat model,” 24(4)Am. J. Sports Med.405-414 (Jul.-Aug. 1996).
Masur et al., “Myofibroblasts differentiate from fibroblasts when plated at low density,” 93(9)Proc. Nat'l Acad. Sci. USA4219-4223 (Apr., 1996).
Murray et al., “Migration of human anterior cruciate ligament fibroblasts into porous collagen-GAG matrices in vitro,” 24thAnnual Meeting of the Society for Biomaterials, Apr. 22-26, 1996, San Diego, CA P.463.
Spindler et al., “Patellar tendon and anterior cruciate ligament have different mitogenic responses to platelet-derived growth factor and transforming growth factor Beta,” 14(4)J. Orthop. Res.542-546 (1996).
Draft guidance document for the preparation of free market notification [510(K)] Applications for Orthopedic Devices, U.S. Food and Drug Administration (Jul. 16, 1997).
Kawamoto et al., “Selective migration of alpha-smooth muscle actin-positive myofibroblasts toward fibronectin in the Boyden's blindwell chamber,” 93(4)Clin. Sci.355-362 (1997).
Louie, “Effect of a porous collagen-glycosaminoglycan copolymer on early tendon healing in a novel animal model,” (Ph.D. Thesis, Massachusetts Institute of Technology, 1997) (copy on file with the MIT Library).
Louie, L. K. et al., “Healing of tendon defects implanted with a porous collagen-GAG matrix: histological evaluation,” 3(2)Tissue Eng'g187-195 (1997).
Stone et al., “Regeneration of Meniscal Cartilage with Use of a Collagen Scaffold,” 79A(12)J. Bone and Joint Surg.1770-1777 (Dec. 1997).
Witkowski et al., “Migration and Healing of Ligament Cells under Inflammatory Conditions,” 15(2)J. Orthop. Res.269-277 (1997).
Yannas, “Models of Organ Regeneration Processes Induces by Templates,”Bioartificial Organs: Science, Medicine, and Technology,Prokop et al. Ed., pp. 280-293 (The New York Academy of Sciences, New York, NY 1997).
Chamberlain, “Long term functional and morphological evaluation of peripheral nerves regenerated through degradable collagen implants,” (M.S. Thesis, Massachusetts Institute of Technology, 1998) (copy on file with the MIT library).
Chamberlain, “Collagen-GAG Substrate Enhances the Quality of Nerve Regeneration through Collagen Tubes up to Level of Autograft,” 154(2)Experimental Neurology315
Marler Jennifer
Murray Martha M.
Murray Michael F.
Pellegrino Brian E.
The Brigham and Women's Hospital, Inc.
Wolf Greenfield & Sacks P.C.
LandOfFree
Biologic replacement for fibrin clot does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologic replacement for fibrin clot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologic replacement for fibrin clot will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3486651